Summit Therapeutics (SMMT)'s 30-day implied volatility (IV30) was 96.1% at the close on November 13, 2026, down from 115.3% the day before, against a 52-week range of 43.5% to 164.0%. Its 20-day historical volatility was 86.5%.
Data as of November 13, 2026.